Skip to main content

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Búsqueda de patrones genéticos predictivos de la evolución del paciente con ictus isquémico después del tratamiento con t-PA

IP: Marc Ribó Jacobi
Collaborators: Joan Montaner Villalonga, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 211145
Reference: PI060586
Duration: 01/01/2007 - 31/03/2010

Geno-tPA: búsqueda de patrones genéticos predictivos de la evolución del paciente con ictus isquémico después del tratamiento con t-PA

IP: Joan Montaner Villalonga
Collaborators: Marc Ribó Jacobi, Manuel Quintana Luque
Funding agency: Fundación Ramón Areces
Funding: 110000
Reference: ARECES/1/2006
Duration: 01/04/2007 - 31/03/2010

RENEVAS - Red de Investigación Cooperativa Neurovascular

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, RENEVAS - Red de Investigación Cooperativa Neurovascular, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 793573.69
Reference: RD06/0026/0010
Duration: 02/01/2007 - 31/12/2013

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50600
Reference: 2005SGR 00614
Duration: 01/01/2006 - 31/12/2008

Related news

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

The award is a recognition for his significant contribution to the development of research in multiple sclerosis within the Catalan Institute of Health.

Related professionals

Sandra Martinez Solà

Sandra Martinez Solà

Secretary
Director
Read more
Yáiza Nuñez Amela

Yáiza Nuñez Amela

Read more
Natalia Avani Da Silva

Natalia Avani Da Silva

Medium Grade Technician
Communication Unit
Communication Directorate
Read more
Rut Mas deles Valls Cierco

Rut Mas deles Valls Cierco

Research technician
Headache and Neurological Pain
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.